These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32727824)

  • 41. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
    Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
    Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An updated review on phytochemistry and molecular targets of
    Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
    Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
    [No Abstract]   [Full Text] [Related]  

  • 43. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
    Kim SH; Singh KB; Hahm ER; Singh SV
    Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Withaferin A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines.
    Das T; Roy KS; Chakrabarti T; Mukhopadhyay S; Roychoudhury S
    Biochem Pharmacol; 2014 Sep; 91(1):31-9. PubMed ID: 24995417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
    Lee IC; Choi BY
    Int J Mol Sci; 2016 Mar; 17(3):290. PubMed ID: 26959007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases.
    Bungau S; Vesa CM; Abid A; Behl T; Tit DM; Purza AL; Pasca B; Todan LM; Endres L
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33919088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.
    Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV
    PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Keeping abreast about ashwagandha in breast cancer.
    Vashi R; Patel BM; Goyal RK
    J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.
    Hahm ER; Lee J; Singh SV
    Mol Carcinog; 2014 Nov; 53(11):907-16. PubMed ID: 24019090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells.
    Stan SD; Zeng Y; Singh SV
    Nutr Cancer; 2008; 60 Suppl 1(Suppl 1):51-60. PubMed ID: 19003581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
    Purushotham PM; Kim JM; Jo EK; Senthil K
    Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.
    Abeesh P; Guruvayoorappan C
    Curr Mol Med; 2024; 24(4):404-418. PubMed ID: 37076466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating anticancer properties of Withaferin A-a potent phytochemical.
    Atteeq M
    Front Pharmacol; 2022; 13():975320. PubMed ID: 36339589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic overview of Withania somnifera, the Indian Ginseng.
    Dar NJ; Hamid A; Ahmad M
    Cell Mol Life Sci; 2015 Dec; 72(23):4445-60. PubMed ID: 26306935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
    Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
    Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
    Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
    Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.
    Okamoto S; Tsujioka T; Suemori S; Kida J; Kondo T; Tohyama Y; Tohyama K
    Cancer Sci; 2016 Sep; 107(9):1302-14. PubMed ID: 27311589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
    Dom M; Offner F; Vanden Berghe W; Van Ostade X
    J Proteomics; 2018 May; 179():17-29. PubMed ID: 29448055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
    Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
    Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.